Table 5 Proportion of actual AIT and AHCL settings at each study visit, compared to those recommended(Phase 1 and Phase 2 intervention periods)
Settings | Phase 1 intervention period | Phase 2 intervention period | P-value |
|---|---|---|---|
Active insulin time = 2 ha | 250(59.1%) | 385(98.0%) | < 0.01 |
Active insulin time > 2 h | 173(40.9%) | 8(2%) | |
Smart Guard target = 5.5 mmol/L (100 mg/dL)b | 401(94.8%) | 377(96.4%) | 0.5 |
Smart Guard target > 5.5 mmol/L (> 100 mg/dL) | 22(5.2%) | 14(3.6%)c |